12
7/16/2019 1 Image-guided Histotripsy for Oncological and Vascular Applications Session: Image-guided Histotripsy for Oncological and Cardiovascular Applications Speaker 3: Zhen Xu Associate Professor and Associate Chair of Graduate Education Department of Biomedical Engineering University of Michigan, Ann Arbor Disclosure Zhen Xu is one of the inventors of intellectual property licensed to Histosonics, Inc.. Co-inventors: Charles Cain, Tim Hall, Brian Fowlkes, and Will Roberts She is a co-founder and holds stock in Histosonics. Histotripsy Xu et al. TUFFC 2004; Parsons et al. UMB 2006 Mechanical Tissue liquefaction generated by inertial cavitation via microsecond-length, high-pressure, pulses at low duty cycle (<<1%) <10 μs …… >15 MPa Bubble cloud 200μm Treated Untreated Intrinsic Threshold: 1-2 cycle pulse, P->30MPa; Shockscattering: P-~15-20 MPa, P+>50MPa, 3-10 cycle pulse,

Image-guided Histotripsy for Oncological and Vascular

  • Upload
    others

  • View
    3

  • Download
    1

Embed Size (px)

Citation preview

Page 1: Image-guided Histotripsy for Oncological and Vascular

7/16/2019

1

Image-guided Histotripsy for Oncological and Vascular

Applications

Session: Image-guided Histotripsy for Oncological and Cardiovascular Applications

Speaker 3: Zhen Xu

Associate Professor and Associate Chair of Graduate EducationDepartment of Biomedical Engineering

University of Michigan, Ann Arbor

Disclosure

• Zhen Xu is one of the inventors of intellectual property licensed to Histosonics, Inc..

– Co-inventors: Charles Cain, Tim Hall, Brian Fowlkes, and Will Roberts

• She is a co-founder and holds stock in Histosonics.

Histotripsy

Xu et al. TUFFC 2004; Parsons et al. UMB 2006

• Mechanical Tissue liquefaction generated by inertial cavitation via microsecond-length, high-pressure, pulses at low duty cycle (<<1%)

<10 µs

……>15 MPa

Bubble cloud

200µm

Treated

Untreated

Intrinsic Threshold: 1-2 cycle pulse, P->30MPa;Shockscattering: P-~15-20 MPa, P+>50MPa, 3-10 cycle pulse,

Page 2: Image-guided Histotripsy for Oncological and Vascular

7/16/2019

2

In Vitro HistotripsyTreatment

Tissue-Fluid Interfaces: Erosion

1 mm

Porcine Atrial Wall

Xu et al., IEEE Trans. Ultrason. Ferroelectr. Freq. Control. 2004, pp. 726;

Parsons, Ultrasound in Med & Biol 2006, vol. 32, pp. 115

25 μm

H&E

Bulk Tissue: Liquefaction

Page 3: Image-guided Histotripsy for Oncological and Vascular

7/16/2019

3

Bubble-cell Interaction

Vlaisavljevich et al. UMB 2016;42(10):2466.

High strain produced by bubble expansion and collapse mechanically disrupts the cells.

SAM Question

• 1. The mechanism of histotripsy-induced tissue disruption is:

• a. High mechanical strain produced by cavitation

• b. Heating by high energy of ultrasound delivered to the focus

• c. All of above

• Answer: a)

BOILING HISTOTRIPSY

Boiling histotripsy process:

1. Shock-wave heating to 100oC within ms

2. Interaction of shocks with vapor cavity

Shock wave

As

T ~ (AS)3

heating 100oC can be reached

in several milliseconds!

1 mm

Vapor bubble!

0.1-1 s

1-20 ms

HIFU pulse

60-100 MPa

10-16 MPa

Example: in vivo porcine kidney

Courtesy of Tanya Khokhlova from University of Washington

Page 4: Image-guided Histotripsy for Oncological and Vascular

7/16/2019

4

Ultrasound Image Guided Histotripsy System

Histotripsy for Cancer Applications

Liver Cancer

Renal Cancer

Prostate Cancer

Pancreatic Cancer

Brain Cancer

Thyroid Cancer

US

Vlaisavljevich et al. Ultrasound Med. Biol, 2013;39:1398-1409

Cavitational Histotripsy in Porcine Liver

Inside In-vivo Porcine Liver

Page 5: Image-guided Histotripsy for Oncological and Vascular

7/16/2019

5

2 cm

Cavitational Histotripsy in Porcine Liver

T2-weighted MRI B-mode Ultrasound

Histotripsy Liver Tumor AblationN1-S1 rodent liver tumor model

MRI in 14/15 treated tumors (6 partial and 9 complete) demonstrated near complete resorption of the ablated tumor in 7-10 weeks.

SAM Question

• 2. What happens to the liquefied tissue homogenate after histotripsy ablation in long term?

• a. Remains in situ and forms scar-like tissue in situ

• b. Remains in situ but does not form scar• c. Goes to blood flow and gets reabsorbed by

the body, results in reduction of the targeted tissue volume

• Answer: (c)

Page 6: Image-guided Histotripsy for Oncological and Vascular

7/16/2019

6

Histotripsy Induces Local Immune Response (Murine Melanoma Model)

Day 3

Day 10

Day -10

Tumor Inoculation Day 0

Histotripsy Ablation

D3 D3 D10 D10

HMGB1 Concentration Post-treatment

D3 D10

CD8+ Intratumoral T-cell Infiltration

CD

8+ T

IL/

tum

or

volu

me

106

cells

/mm

(3)

ng/

uL

Histotripsy (HT) Induces Systemic

Immune Response

Day 0

Histotripsy

Day

10

Tumor and Lung harvest

Day -10

Tumor Inoculations

Day -7

Tail-vein Injections

Histotripsy (HT) Induces Systemic

Immune Response

Day 0

Histotripsy

Day

10

Tumor and Lung harvest

Day -10

Tumor Inoculations

Day -7

Tail-vein Injections

C)A) Control

B) Histotripsy

Control Histotripsy

# p

ulm

on

ary

met

asta

ses

Pulmonary Metastases

Page 7: Image-guided Histotripsy for Oncological and Vascular

7/16/2019

7

BOILING HISTOTRIPSY

NON-INVASIVE LIQUID BIOPSY TOOL

Blood-based cancer biomarker – a cancer-specific molecule secreted by the

tumor into the circulation

MicroRNAs – promising class of blood-based biomarkers, but low baseline

release levels

Chevillet, Khokhlova et al. Radiology 2016

Rat prostate

cancer model

(MatLyLu)

Liquefaction

via BH

Tumor-associated miRNA:

over 20-fold increase

Time post BH (min)

Broadly expressed control

Courtesy of Tanya Khokhlova from University of Washington

Thrombosis

Deep Vein Thrombosis

Large Hematoma Evacuation

Non-invasive Thrombolysis

• Thrombosis - blood clot formation, cause of

many vascular diseases, such as deep vein

thrombosis, stroke, etc.

• Current techniques have drawbacks:

– Thrombolytic Drugs – Slow reperfusion,

excessive bleeding

– Catheters – Invasiveness, bleeding, and infection

Page 8: Image-guided Histotripsy for Oncological and Vascular

7/16/2019

8

Histotripsy Thrombolysis Porcine Deep Vein Thrombosis Model

Clot

Maxwell et al J Vasc Interv Radiol. 2011; 22: 369-77

Histotripsy Thrombolysis Porcine Deep Vein Thrombosis Model

x x x x x

Maxwell et al J Vasc Interv Radiol. 2011; 22: 369-77

Histotripsy Thrombolysis Porcine Deep Vein Thrombosis Model

x x x x xxxx xxx x xx x x x

Maxwell et al J Vasc Interv Radiol. 2011; 22: 369-77

Page 9: Image-guided Histotripsy for Oncological and Vascular

7/16/2019

9

Maxwell et al J Vasc Interv Radiol. 2011; 22: 369-77

Histotripsy Thrombolysis Porcine Deep Vein Thrombosis Model

Zhang et al. UMB 2017

Histotripsy Thrombolysis: B-mode and Doppler Post-treatment

Histotripsy Thrombolysis: Vessel Damage (2 weeks)

2 Weeks After Microtripsy Thrombolysis Treatment

Page 10: Image-guided Histotripsy for Oncological and Vascular

7/16/2019

10

Boiling Histotripsy For Liquefaction And Aspiration

Of Large Hematomas

Large (up to 1-2 L) hematomas often caused by trauma or post-surgical

bleeds

Health effects:

• pain

• compartment

syndrome

• organ failure

• risk of infection

Clinical

management:

• Surgery

• Indwelling

drain

(ineffective)

Approach: fast liquefaction with boiling

histotripsy, simultaneously drain with fine

needle

In vitro phantom

Highest

liquefaction rate

achieved to date:

16 mL/min Courtesy of Tanya Khokhlova from University of Washington

Histotripsy for Brain Applications

Brain Tumor

Hemorrhagic Stroke

Transcranial (Cavitational) Histotripsy

250/500kHz 256E hemispherical array

30 cm diameter15 cm focal distance

Can ablate brain tumor or liquefy clot through human skull in deep and shallow locations in the brain

Sukovich et al. TUFFC 2016; Gerhardson et al., TUFFC; 2017

Page 11: Image-guided Histotripsy for Oncological and Vascular

7/16/2019

11

Transcranial Histotripsy In vitro bovine brain ablation through human skull

Capability to • ablate a volume• ablate near skull

surface (5mm)• Skull heating

(<4℃)

Gerhardson et al., UMB, 43(10):2302-17

Histotripsy in the In Vivo Porcine Brain

Sukovich et al., J. Neurosurgery, 2018

Acknowledgement

• Scientific Collaborators (PhD)– Charles A. Cain (BME)– Timothy L. Hall (BME)– J. Brian Fowlkes (Radiology)– Jonathan Sukovich (BME)– Eric Johnsen (ME)– James Balter (Radiation Oncology)

• Ph.D. Students and Postdocs– Jonathan Lundt– Jonathan Macoskey– Tyler Gerhardson– Hedieh Tamaddoni– Yige Li– Sang Won Choi– Tejaswi Warlikar– Ryan Hubbard– Ellen Yeats– Ning Lu– Greyson Stocker

• Clinical Collaborators (MD)– Aditya Pandey (Neurosurgery)

– Gabe Owens (Pediatric Cardiology)

– William Roberts (Urology)

– Clifford Cho (Surgery)

– Mishal Mendiratta-Lala (Radiology)

– Fred Lee (Radiology – U. Wisconsin)

– Hitinder Gurm (Interventional Cardiology)

• Funding Support– NIH (R01 CA 211217, R01 EB 008998, R01

NS108042, R01 DK 091267) – American Cancer Society (RSG-13-101-01-

CCE)– Focused Ultrasound Foundation– American Heart Association

Page 12: Image-guided Histotripsy for Oncological and Vascular

7/16/2019

12

The End

Thank you!

Questions?

• Brain Tumor Treatment• Craniotomy surgery - invasive

• Chemotherapy – blood brain barrier

• Radiation therapy – normal brain structure susceptible to radiation damage

• Hemorrhagic stroke treatment• Medical management – no active clot reduction

• Craniopuncture (tPA + catheter drainage) – Slow

• MR guided Focused Ultrasound (MRgFUS)• Essential Tremor

• Can only treat a small volume in the central region of the brain

Brain Diseases and Treatment Options